Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Aspas Requena G, Montesinos P, Bérard E, Bertoli S, Rodríguez-Veiga R, Simand C, Torres L, Peterlin P, Tormo M, Birsen R, Bergua-Burgues JM, Tavernier E, Bernal Del Castillo T, Carré M, Gil C, Contejean A, Rodríguez-Arbolí E, Orvain C, Rodríguez-Medina C, Veronese L, Sayas Lloris MJ, Delabesse E, Serrano J, Mineur A, García-Fortes M, Guieze R, Amigo ML, Pigneux A, Algarra Algarra L, Recher C, Dumas PY, Martínez-Cuadrón D

Open source

DOI: 10.1002/ajh.70233
Published: 2026 May
Container: American journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70233,
  title = {Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.},
  author = {Aspas Requena G and Montesinos P and Bérard E and Bertoli S and Rodríguez-Veiga R and Simand C and Torres L and Peterlin P and Tormo M and Birsen R and Bergua-Burgues JM and Tavernier E and Bernal Del Castillo T and Carré M and Gil C and Contejean A and Rodríguez-Arbolí E and Orvain C and Rodríguez-Medina C and Veronese L and Sayas Lloris MJ and Delabesse E and Serrano J and Mineur A and García-Fortes M and Guieze R and Amigo ML and Pigneux A and Algarra Algarra L and Recher C and Dumas PY and Martínez-Cuadrón D},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70233},
  url = {https://doi.org/10.1002/ajh.70233}
}

RIS

TY  - JOUR
TI  - Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.
AU  - Aspas Requena G
AU  - Montesinos P
AU  - Bérard E
AU  - Bertoli S
AU  - Rodríguez-Veiga R
AU  - Simand C
AU  - Torres L
AU  - Peterlin P
AU  - Tormo M
AU  - Birsen R
AU  - Bergua-Burgues JM
AU  - Tavernier E
AU  - Bernal Del Castillo T
AU  - Carré M
AU  - Gil C
AU  - Contejean A
AU  - Rodríguez-Arbolí E
AU  - Orvain C
AU  - Rodríguez-Medina C
AU  - Veronese L
AU  - Sayas Lloris MJ
AU  - Delabesse E
AU  - Serrano J
AU  - Mineur A
AU  - García-Fortes M
AU  - Guieze R
AU  - Amigo ML
AU  - Pigneux A
AU  - Algarra Algarra L
AU  - Recher C
AU  - Dumas PY
AU  - Martínez-Cuadrón D
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70233
UR  - https://doi.org/10.1002/ajh.70233
ER  -

APA

G, A. R., P, M., E, B., S, B., R, R., C, S., L, T., P, P., M, T., R, B., JM, B., E, T., T, B. D. C., M, C., C, G., A, C., E, R., C, O., C, R., L, V., MJ, S. L., E, D., J, S., A, M., M, G., R, G., ML, A., A, P., L, A. A., C, R., PY, D., & D, M. (2026). Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.. American journal of hematology. https://doi.org/10.1002/ajh.70233

Source records

pubmed · retrieved 2026-09-27T09:25:45.345Z